DR Horton Stock

Equities

DHI

US23331A1097

Homebuilding

Real-time Estimate Cboe BZX 11:52:02 2024-04-23 am EDT 5-day change 1st Jan Change
147.9 USD +3.39% Intraday chart for DR Horton +1.21% -2.74%
Sales 2024 * 36.95B Sales 2025 * 39.39B Capitalization 47.24B
Net income 2024 * 4.71B Net income 2025 * 5.01B EV / Sales 2024 * 1.32 x
Net Debt 2024 * 1.36B Net Debt 2025 * 876M EV / Sales 2025 * 1.22 x
P/E ratio 2024 *
10.1 x
P/E ratio 2025 *
9.2 x
Employees 13,450
Yield 2024 *
0.84%
Yield 2025 *
0.9%
Free-Float 74.26%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.62%
1 week-4.02%
Current month-13.05%
1 month-11.59%
3 months-9.28%
6 months+42.13%
Current year-5.86%
More quotes
1 week
141.20
Extreme 141.2
154.26
1 month
141.20
Extreme 141.2
165.75
Current year
138.83
Extreme 138.83
165.75
1 year
100.08
Extreme 100.08
165.75
3 years
59.25
Extreme 59.25
165.75
5 years
25.51
Extreme 25.51
165.75
10 years
19.29
Extreme 19.29
165.75
More quotes
Managers TitleAgeSince
Founder 74 77-12-31
Chief Executive Officer 54 98-12-31
Director of Finance/CFO 58 97-12-31
Members of the board TitleAgeSince
Founder 74 77-12-31
Director of Finance/CFO 58 97-12-31
Director/Board Member 78 14-01-22
More insiders
Date Price Change Volume
24-04-23 148 +3.47% 681 976
24-04-22 143.1 +0.62% 3,108,892
24-04-19 142.2 -2.53% 3,393,602
24-04-18 145.9 +0.10% 5,503,894
24-04-17 145.7 -0.21% 3,183,255

Delayed Quote Nyse, April 22, 2024 at 04:00 pm EDT

More quotes
D.R. Horton, Inc. is one of the leading American single-family homebuilders. Net sales break down by activity as follows: - construction of single-family homes and development of lots (90.4%): home sales (detached homes, attached homes, etc.; operating under the names D.R. Horton, America's Builder, Emerald Homes, Express Homes, Freedom Homes and Pacific Ridge Homes) and lot sales; - property rental (7.3%); - supply of financial services (2.3%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
143.1 USD
Average target price
168.2 USD
Spread / Average Target
+17.54%
Consensus